Genesis Minerals posts record production, strong cash in December 2025 quarter

Genesis Minerals posts record gold production and robust cash growth, keeping its FY26 outlook on track and advancing Tower Hill early.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Genesis Minerals Ltd (ASX: GMD) share price is in focus as the gold miner delivered record December-quarter production of 74,261 ounces and grew cash and equivalents to $404 million, all while maintaining tight cost controls.

Happy miner giving ok sign in front of a mine.

Image source: Getty Images

What did Genesis Minerals report?

  • Record quarterly gold production of 74,261 ounces at an all-in sustaining cost (AISC) of $2,635 per ounce
  • Half-year production of 147,139 ounces at an AISC of $2,578/oz
  • Gold sales of 71,346 ounces at an average price of $6,057/oz, generating revenue of $432.2 million
  • Cash and equivalents of $403.6 million at 31 December 2025, with no bank debt
  • Unaudited half-year NPAT between $235 million and $245 million
  • FY26 production outlook maintained at 260,000–290,000oz at an AISC of $2,500–$2,700/oz

What else do investors need to know?

Genesis accelerated its Tower Hill development, achieving major milestones ahead of schedule. These included finalising rail agreements, a mining agreement with the Darlot People, and key government approvals. Operational readiness activities are progressing well, with site establishment works to commence soon.

The miner also awarded a Letter of Intent to Byrnecut for underground mining at Leonora, with full mobilisation planned for May 2026. Genesis maintained a strong focus on sustainability, reporting no lost time injuries for the quarter and releasing new group-wide environmental standards.

What did Genesis Minerals management say?

Executive Chair Raleigh Finlayson said:

We have met or exceeded all our operational targets while making strong progress on our growth agenda. Our record production was accompanied by tight cost control, which was a significant achievement given the cost pressures faced across the industry, and as we continue to lay the foundations to deliver our ASPIRE accelerated growth strategy ahead of schedule. We look forward to unveiling details of our longer-term plan later in the current half, including the mill expansion strategy, as we seek to capitalise on the strength of the long ore position we have established.

What's next for Genesis Minerals?

Genesis is pushing ahead with its "ASPIRE 400" strategy, aiming to accelerate production growth beyond previous 10-year plans. The Tower Hill project remains a major focus and is on track for first ore in FY28. The company raised its FY26 growth capital outlook to $220–240 million, reflecting earlier development at Tower Hill and associated projects.

An updated long-term plan, including mill expansion studies, is set for release in the June half of 2026. Genesis also expects to become liable for income tax instalments in the current financial year as it fully utilises carried-forward losses.

Genesis Minerals share price snapshot

Over the past 12 months, Genesis Minerals shares have soared 166%, strongly outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 5% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Share Market News

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

A disappointed man slumps in his chair and holds his head while playing an online game.
52-Week Lows

These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?

Should investors buy in the dip or sit on the sidelines?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Beach Energy, Domino's, Origin Energy, and Pantoro Gold shares are dropping today

Why are these shares under pressure? Let's find out.

Read more »

A woman wearing a hard hat holds two sparking wires together as energy surges between them.
Share Market News

Origin Energy shares slump 10% this week: Buy, sell or hold?

The ASX energy company has hit some headwinds. How much longer can they continue?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »